179 related articles for article (PubMed ID: 25141250)
21. The optimal treatment of severe hypertension in pregnancy: update of the role of nicardipine.
Nooij LS; Visser S; Meuleman T; Vos P; Roelofs R; de Groot CJ
Curr Pharm Biotechnol; 2014; 15(1):64-9. PubMed ID: 24720593
[TBL] [Abstract][Full Text] [Related]
22. Nicardipine versus Labetalol for Hypertension during Acute Stroke: A Systematic Review and Meta-Analysis.
Hao F; Yin S; Tang L; Zhang X; Zhang S
Neurol India; 2022; 70(5):1793-1799. PubMed ID: 36352567
[TBL] [Abstract][Full Text] [Related]
23. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial.
Raheem IA; Saaid R; Omar SZ; Tan PC
BJOG; 2012 Jan; 119(1):78-85. PubMed ID: 21985500
[TBL] [Abstract][Full Text] [Related]
24. Hypertensive emergencies: an update.
Marik PE; Rivera R
Curr Opin Crit Care; 2011 Dec; 17(6):569-80. PubMed ID: 21986463
[TBL] [Abstract][Full Text] [Related]
25. Labetalol Use Is Associated With Increased In-Hospital Infection Compared With Nicardipine Use in Intracerebral Hemorrhage.
Starr JB; Tirschwell DL; Becker KJ
Stroke; 2017 Oct; 48(10):2693-2698. PubMed ID: 28904237
[TBL] [Abstract][Full Text] [Related]
26. Systolic blood pressure lowering to 160 mmHg or less using nicardipine in acute intracerebral hemorrhage: a prospective, multicenter, observational study (the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-Intracerebral Hemorrhage study).
Koga M; Toyoda K; Yamagami H; Okuda S; Okada Y; Kimura K; Shiokawa Y; Nakagawara J; Furui E; Hasegawa Y; Kario K; Osaki M; Miyagi T; Endo K; Nagatsuka K; Minematsu K;
J Hypertens; 2012 Dec; 30(12):2357-64. PubMed ID: 22990355
[TBL] [Abstract][Full Text] [Related]
27. Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: a randomized clinical trial.
Vigil-De Gracia P; Ruiz E; López JC; de Jaramillo IA; Vega-Maleck JC; Pinzón J
Hypertens Pregnancy; 2007; 26(2):163-71. PubMed ID: 17469006
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of intravenous labetalol for hypertensive crisis in infants and small children.
Thomas CA; Moffett BS; Wagner JL; Mott AR; Feig DI
Pediatr Crit Care Med; 2011 Jan; 12(1):28-32. PubMed ID: 20495503
[TBL] [Abstract][Full Text] [Related]
29. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
Weiss RJ; Stapff M; Lin Y
Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
[TBL] [Abstract][Full Text] [Related]
30. Intravenous nicardipine for treatment of postcoarctectomy hypertension in children.
Nakagawa TA; Sartori SC; Morris A; Schneider DS
Pediatr Cardiol; 2004; 25(1):26-30. PubMed ID: 14534761
[TBL] [Abstract][Full Text] [Related]
31. Retrospective evaluation of nicardipine versus labetalol for blood pressure control in aneurysmal subarachnoid hemorrhage.
Woloszyn AV; McAllen KJ; Figueroa BE; DeShane RS; Barletta JF
Neurocrit Care; 2012 Jun; 16(3):376-80. PubMed ID: 22528277
[TBL] [Abstract][Full Text] [Related]
32. [Antihypertensive effects of intravenous nicardipine in arterial hypertension in the elderly].
Escande M; David D; Diadema B
Therapie; 1989; 44(3):161-5. PubMed ID: 2675376
[TBL] [Abstract][Full Text] [Related]
33. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
[TBL] [Abstract][Full Text] [Related]
34. Nicardipine as antihypertensive monotherapy: positive effects on quality of life.
Weir MR; Josselson J; Ekelund LG; Korc M; Pool JL; Stein GH; Wolbach RA; Champion D
J Hum Hypertens; 1991 Jun; 5(3):205-13. PubMed ID: 1920344
[TBL] [Abstract][Full Text] [Related]
35. Intravenous nicardipine for treatment of severe hypertension in children.
Flynn JT; Mottes TA; Brophy PD; Kershaw DB; Smoyer WE; Bunchman TE
J Pediatr; 2001 Jul; 139(1):38-43. PubMed ID: 11445792
[TBL] [Abstract][Full Text] [Related]
36. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial.
Vigil-De Gracia P; Lasso M; Ruiz E; Vega-Malek JC; de Mena FT; López JC;
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):157-62. PubMed ID: 16621226
[TBL] [Abstract][Full Text] [Related]
37. Blood Pressure Control in Acute Stroke: Labetalol or Nicardipine?
El-Ghoroury H; Sudekum DM; Hecht JP
J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105959. PubMed ID: 34217067
[TBL] [Abstract][Full Text] [Related]
38. Postoperative hypertension: a multicenter, prospective, randomized comparison between intravenous nicardipine and sodium nitroprusside.
Halpern NA; Goldberg M; Neely C; Sladen RN; Goldberg JS; Floyd J; Gabrielson G; Greenstein RJ
Crit Care Med; 1992 Dec; 20(12):1637-43. PubMed ID: 1458938
[TBL] [Abstract][Full Text] [Related]
39. Treatment of isolated systolic hypertension with labetalol in the elderly.
Giles TD; Weber M; Bartels DW; Silberman HM; Gilderman LP; Burris JF
Arch Intern Med; 1990 May; 150(5):974-6. PubMed ID: 2184794
[TBL] [Abstract][Full Text] [Related]
40. Intravenous nicardipine for the treatment of severe hypertension. A double-blind, placebo-controlled multicenter trial.
Wallin JD; Fletcher E; Ram CV; Cook ME; Cheung DG; MacCarthy EP; Townsend R; Saunders E; Davis WR; Langford HG
Arch Intern Med; 1989 Dec; 149(12):2662-9. PubMed ID: 2688586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]